Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to -$77.3 million.

  • Sotera Health's Cash from Financing Activities fell 281405.43% to -$77.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.9 million, marking a year-over-year decrease of 10687.95%. This contributed to the annual value of -$50.6 million for FY2024, which is 11901.2% down from last year.
  • As of Q3 2025, Sotera Health's Cash from Financing Activities stood at -$77.3 million, which was down 281405.43% from -$6.9 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Cash from Financing Activities registered a high of $273.9 million during Q1 2023, and its lowest value of -$103.4 million during Q3 2021.
  • Its 5-year average for Cash from Financing Activities is $10.7 million, with a median of -$3.8 million in 2021.
  • In the last 5 years, Sotera Health's Cash from Financing Activities soared by 6110579.06% in 2023 and then crashed by 404380.28% in 2024.
  • Quarter analysis of 5 years shows Sotera Health's Cash from Financing Activities stood at -$1.8 million in 2021, then skyrocketed by 11280.92% to $199.2 million in 2022, then tumbled by 101.9% to -$3.8 million in 2023, then crashed by 72.63% to -$6.5 million in 2024, then plummeted by 1081.11% to -$77.3 million in 2025.
  • Its Cash from Financing Activities stands at -$77.3 million for Q3 2025, versus -$6.9 million for Q2 2025 and -$8.1 million for Q1 2025.